ES2149043T3 - Compuestos glicerolipidicos utiles para la transferencia de una substancia activa a una celula diana. - Google Patents

Compuestos glicerolipidicos utiles para la transferencia de una substancia activa a una celula diana.

Info

Publication number
ES2149043T3
ES2149043T3 ES98908156T ES98908156T ES2149043T3 ES 2149043 T3 ES2149043 T3 ES 2149043T3 ES 98908156 T ES98908156 T ES 98908156T ES 98908156 T ES98908156 T ES 98908156T ES 2149043 T3 ES2149043 T3 ES 2149043T3
Authority
ES
Spain
Prior art keywords
active substance
glycerolipidic
transfer
target cell
compounds useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98908156T
Other languages
English (en)
Inventor
Rainer Bischoff
Denis Heissler
Abdesslame Nazih
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9701475A external-priority patent/FR2759367A1/fr
Application filed by Transgene SA filed Critical Transgene SA
Application granted granted Critical
Publication of ES2149043T3 publication Critical patent/ES2149043T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS COMPUESTOS DE FORMULA (I) EN LA QUE: R 1 Y R 2 IDENTICOS O DIFERENTES SON RADICALES C 6 - C 23 ALQUILO O ALCENILO, LINEALES O RAM IFICADOS O RADICALES - C(=O) - (C 6 - C 23 ) ALQUILO O - C(=O) - (C 6 C 23 ) ALCENILO LINEALES O RAMIFICADOS. X ES EL ATOMO DE OXIGENO O UN RADICAL AMINO -NR 3 , SI ENDO R 3 UN ATOMO DE HIDROGENO O UN RADICAL ALQUILO INFERIOR DE 1 A 4 ATOMOS DE CARBONO, N ES UN NUMERO ENTERO POSITIVO DE 1 A 6; M ES UN NUMERO ENTRO POSITIVO DE 1 A 6 Y CUANDO N > 1, M PUEDE SER IDENTICO O DIFERENTE. LA INVENCION SE REFIERE TAMBIEN A NUEVOS COMPLEJOS DE COMPUESTOS SEGUN LA INVENCION Y DE SUSTANCIAS ACTIVAS EN PARTICULAR TERAPEUTICAMENTE, QUE LLEVAN AL MENOS UNA CARGA NEGATIVA QUE PERMITE LA INTRODUCCION DE DICHAS SUSTANCIAS ACTIVAS A LAS CELULAS. LA INVENCION SE REFIERE TAMBIEN EN PARTICULAR A NUEVOS COMPLEJOS, CUYA SUSTANCIA ACTIVA CONSISTE EN UNO O VARIOS ACIDOS NUCLEICOS, UTILES PARA TRANSFECTAR LAS CELULAS.
ES98908156T 1997-02-10 1998-02-10 Compuestos glicerolipidicos utiles para la transferencia de una substancia activa a una celula diana. Expired - Lifetime ES2149043T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701475A FR2759367A1 (fr) 1997-02-10 1997-02-10 Glycerolipides cationiques et complexes de glycerolipides cationiques et de substances actives, notamment pour la transfection de cellules
FR9715805A FR2759382A1 (fr) 1997-02-10 1997-12-12 Nouveaux composes et compositions les contenant utilisables pour le transfert d'au moins une substance therapeutiquement active, notamment un polynucleotide, dans une cellule cible et utilisation en therapie genique

Publications (1)

Publication Number Publication Date
ES2149043T3 true ES2149043T3 (es) 2000-10-16

Family

ID=26233309

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98908156T Expired - Lifetime ES2149043T3 (es) 1997-02-10 1998-02-10 Compuestos glicerolipidicos utiles para la transferencia de una substancia activa a una celula diana.

Country Status (13)

Country Link
US (2) US6218370B1 (es)
EP (1) EP0901463B1 (es)
JP (1) JP2000510869A (es)
AT (1) ATE193886T1 (es)
AU (1) AU727204B2 (es)
CA (1) CA2251999A1 (es)
DE (1) DE69800178T2 (es)
DK (1) DK0901463T3 (es)
ES (1) ES2149043T3 (es)
FR (1) FR2759382A1 (es)
GR (1) GR3034317T3 (es)
PT (1) PT901463E (es)
WO (1) WO1998034910A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2759382A1 (fr) * 1997-02-10 1998-08-14 Transgene Sa Nouveaux composes et compositions les contenant utilisables pour le transfert d'au moins une substance therapeutiquement active, notamment un polynucleotide, dans une cellule cible et utilisation en therapie genique
US6849272B1 (en) * 1999-04-21 2005-02-01 Massachusetts Institute Of Technology Endosomolytic agents and cell delivery systems
EP1052287A3 (en) * 1999-05-10 2003-07-09 Transgene S.A. Complex for transferring an anionic substance of interest into a cell
EP1052288A1 (en) * 1999-05-10 2000-11-15 Transgene S.A. Complex for transferring an anionic substance of interest into a cell
AU2637500A (en) * 1999-12-10 2001-06-18 Genzyme Corporation Cationic amphiphiles for intracellular delivery of therapeutic molecules
US20030229037A1 (en) * 2000-02-07 2003-12-11 Ulrich Massing Novel cationic amphiphiles
GB0106041D0 (en) * 2001-03-12 2001-05-02 Cancer Res Ventures Ltd Lipids and liposomes
US20070111201A1 (en) * 2001-04-30 2007-05-17 Benjamin Doranz Reverse transfection of cell arrays for structural and functional analyses of proteins
US20050261214A1 (en) * 2001-05-15 2005-11-24 Serge Braun Complexes for transferring substances of interest into a cell
EP1513853A2 (en) * 2002-05-24 2005-03-16 Neopharm, Inc. Cardiolipin compositions, methods of preparation and use
EA200401565A1 (ru) * 2002-05-24 2005-04-28 Неофарм, Инк. Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
US20050277611A1 (en) * 2002-10-16 2005-12-15 Neopharm, Inc. Cationic cardiolipin analoges and its use thereof
CN1826410B (zh) 2003-07-21 2011-10-26 特兰斯吉恩股份有限公司 具有改良的胞嘧啶脱氨酶活性的多肽
WO2005039558A1 (en) * 2003-10-24 2005-05-06 Transgene S.A. Targeted delivery of therapeutically active compounds
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
WO2005056752A2 (en) 2003-10-24 2005-06-23 Gencia Corporation Methods and compositions for delivering polynucleotides
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
EP1743440B1 (en) * 2004-08-05 2009-10-07 LG Electronics, Inc. Interrupting use of frequency layer convergence scheme
GB0425556D0 (en) * 2004-11-19 2004-12-22 Glaxo Group Ltd Novel compounds
JP5172188B2 (ja) * 2007-03-28 2013-03-27 富士フイルム株式会社 フッ素置換アルキル基を有するグリセリド化合物
US8357531B2 (en) 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
FR2921369B1 (fr) * 2007-09-25 2014-07-11 Pf Medicament Nouveau procede de preparation de derives (poly) aminoalkylaminoacetamide d'epipodophyllotoxine,utiles pour leurs applications en therapeutique comme agent anticancereux.
US8470977B2 (en) 2008-03-14 2013-06-25 Transgene S.A. Antibody against the CSF-1R
MX2011007494A (es) 2009-01-13 2011-08-12 Transgene Sa Uso de una fraccion de la mitocondria de acidos nucleicos de saccharomyces cerevisiae para la estimulacion inmune.
US11826423B2 (en) 2016-11-16 2023-11-28 Immunomic Therapeutics, Inc. Nucleic acids for treatment of allergies
US11203629B2 (en) 2017-04-22 2021-12-21 Immunomic Therapeutics, Inc. LAMP constructs
CA3061950A1 (en) 2017-05-02 2018-11-08 Immunomic Therapeutics, Inc. Lamp (lysosomal associated membrane protein) constructs comprising cancer antigens
EP3793595A1 (en) 2018-05-15 2021-03-24 Immunomic Therapeutics, Inc. Improved lamp constructs comprising allergens
TWI852977B (zh) 2019-01-10 2024-08-21 美商健生生物科技公司 前列腺新抗原及其用途
JP2022551732A (ja) 2019-10-18 2022-12-13 イミュノミック セラピューティックス， インコーポレイテッド がん抗原を含む改良ｌａｍｐ構築物
CN114980920A (zh) 2019-11-18 2022-08-30 詹森生物科技公司 基于突变体calr和jak2的疫苗及其用途
WO2022009051A1 (en) 2020-07-06 2022-01-13 Janssen Biotech, Inc. A method for determining responsiveness to prostate cancer treatment
WO2022009052A2 (en) 2020-07-06 2022-01-13 Janssen Biotech, Inc. Prostate neoantigens and their uses
US20230024133A1 (en) 2020-07-06 2023-01-26 Janssen Biotech, Inc. Prostate Neoantigens And Their Uses
CA3247515A1 (en) 2022-04-10 2023-10-19 Immunomic Therapeutics, Inc. Bicistronic lamp constructions comprising genes that enhance the immune response and methods of their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2958076B2 (ja) * 1990-08-27 1999-10-06 株式会社ビタミン研究所 遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
US5334761A (en) * 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
AU6045094A (en) * 1993-02-19 1994-09-14 Nippon Shinyaku Co. Ltd. Drug composition containing nucleic acid copolymer
DE19521412A1 (de) 1995-06-14 1996-12-19 Boehringer Mannheim Gmbh Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung
GB9512363D0 (en) * 1995-06-17 1995-08-16 Bass Plc Liquid containers and method of manufacture thereof
FR2759382A1 (fr) * 1997-02-10 1998-08-14 Transgene Sa Nouveaux composes et compositions les contenant utilisables pour le transfert d'au moins une substance therapeutiquement active, notamment un polynucleotide, dans une cellule cible et utilisation en therapie genique

Also Published As

Publication number Publication date
ATE193886T1 (de) 2000-06-15
FR2759382A1 (fr) 1998-08-14
GR3034317T3 (en) 2000-12-29
AU6626698A (en) 1998-08-26
US6218370B1 (en) 2001-04-17
DK0901463T3 (da) 2000-10-23
US20010036927A1 (en) 2001-11-01
US6743781B2 (en) 2004-06-01
WO1998034910A1 (fr) 1998-08-13
JP2000510869A (ja) 2000-08-22
DE69800178D1 (de) 2000-07-20
EP0901463B1 (fr) 2000-06-14
PT901463E (pt) 2000-12-29
EP0901463A1 (fr) 1999-03-17
AU727204B2 (en) 2000-12-07
DE69800178T2 (de) 2001-02-15
CA2251999A1 (fr) 1998-08-13

Similar Documents

Publication Publication Date Title
GR3034317T3 (en) Glycerolipidic compounds used for the transfer of an active substance into a target cell
DK0659174T3 (da) Derivater af valproinsyre og 2-valproensyreamider samt deres anvendelse som antikonvulsive midler
IS7170A (is) Bensóþíasepín og bensóþíadíasepínafleiður með tálmavirkni gegn dausgarnargallsýruflutningi (ileal bile acid transport, IBAT) til að meðhöndla fitudreyra
NZ290757A (en) Delivery of nucleic acid into a cell
CA2222329A1 (en) 4-substituted-phenyl-boronic acids as enzyme stabilizers
DE60023531D1 (de) Spezifische acylierte gylcerolverbindungen als weichmacher für polymere
HU9502811D0 (en) N-acyl-sulfamic acid esters (or thioesters), n-acyl-sulfonamides and n-sulfonyl-carbamic-acid-esters (or thioesters) as hypercholesterolemic agents
SE0000772D0 (sv) Chemical compounds
ES2147376T3 (es) Composicion de electrolito polimero basada en la quimica de los tiol-enos.
CA2108885A1 (fr) Monomeres derives de sultones perhalogenees et polymeres obtenus a partir de ces monomeres
EA199901047A1 (ru) Жидкие производные бензизохинолина
PL375196A1 (en) Collecting agent for sulphidic ores
DE69825626D1 (de) Heterozyklische cytotoxische wirkstoffe
IT1249732B (it) Oligonucleotidi antisenso.
GB2324528B (en) Cytostatic hydroxamic acid derivatives
ES8506113A1 (es) Un metodo de electrodepositar una superficie electroconductora que sirve como electrodo
MX170732B (es) Composicion de derivados de succinimida y su uso
BR9813923A (pt) N n - bis(sulfonil) hidrazinas úteis como agentes antineoplásicos
NO953347L (no) Triglyserid kontrastmiddel
TR199902433T2 (xx) Yeni piridin t�revleri ve bunlar� i�eren ispen�iyari bile�imler.
EA200001107A1 (ru) ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ
EP0855418A3 (en) High purity branched phenylsiloxane fluids
ES8303434A1 (es) Procedimiento para la obtencion de amidas del ester de acido fosforico (fosfonico).
ATE61341T1 (de) N-substituierte, estergruppen enthaltende acrylamide.
PE2099A1 (es) Derivados de acido hidroxamico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 901463

Country of ref document: ES